EP12.01. L858R Exon 21 Mutation Is Associated with a Higher Risk of Brain Metastases in Patients with NSCLC Treated with TKI - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Oscar Arrieta
Meta Tag
Speaker Oscar Arrieta
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
brain metastases
non-small cell lung cancer
EGFR targeted therapy
EGFR mutations
exon 19 deletion
L858R mutation
risk assessment
intracranial progression-free survival
CNS lesions
Powered By